<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Android-Android.de &#187; Genmabs</title>
	<atom:link href="http://www.android-android.de/tag/genmabs/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.android-android.de</link>
	<description></description>
	<lastBuildDate>Thu, 24 May 2018 15:49:44 +0000</lastBuildDate>
	<language>de-DE</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>DGAP-Adhoc: Genmab Unveils A New Antibody Technology Platform: HexaBody
 &#124; Dow Jones News auf 4investors.de</title>
		<link>http://www.android-android.de/dgap-adhoc-genmab-unveils-a-new-antibody-technology-platform-hexabody-dow-jones-news-auf-4investors-de/2012-12-17/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dgap-adhoc-genmab-unveils-a-new-antibody-technology-platform-hexabody-dow-jones-news-auf-4investors-de</link>
		<comments>http://www.android-android.de/dgap-adhoc-genmab-unveils-a-new-antibody-technology-platform-hexabody-dow-jones-news-auf-4investors-de/2012-12-17/#comments</comments>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dc:creator>Nachrichten</dc:creator>
				<category><![CDATA[Android Apps]]></category>
		<category><![CDATA[announcement]]></category>
		<category><![CDATA[antibody]]></category>
		<category><![CDATA[clinical]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Genmab]]></category>
		<category><![CDATA[Genmabs]]></category>
		<category><![CDATA[HexaBody]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[results]]></category>
		<category><![CDATA[statements]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[therapeutics]]></category>
		<category><![CDATA[UNVEILS]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[17.12.2012 &#8211; DJ DGAP-Adhoc: Genmab Unveils A New Antibody Technology Platform: HexaBody Genmab A/S 17.12.2012 08:28 Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. =&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; Company Announcement &#8212; HexaBody Quelle: 4investors&#8230; [weiterlesen]]]></description>
				<content:encoded><![CDATA[<p>17.12.2012 &#8211; </p>
<p>DJ DGAP-Adhoc: Genmab Unveils A New Antibody Technology Platform: HexaBody</p>
<p>Genmab A/S </p>
<p>17.12.2012 08:28 </p>
<p>Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of<br />
EquityStory AG.<br />
The issuer is solely responsible for the content of this announcement. </p>
<p>=&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; </p>
<p>Company Announcement </p>
<p>  &#8212; HexaBody Quelle: 4investors&#8230; <a href="http://www.4investors.de/php_fe/indexdow.php?sektion=dowjones&#038;ID=293875" nofollow>[weiterlesen]</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.android-android.de/dgap-adhoc-genmab-unveils-a-new-antibody-technology-platform-hexabody-dow-jones-news-auf-4investors-de/2012-12-17/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH
 &#124; Dow Jones News auf 4investors.de</title>
		<link>http://www.android-android.de/dgap-adhoc-new-preliminary-efficacy-data-for-daratumumab-presented-at-ash-dow-jones-news-auf-4investors-de/2012-12-09/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dgap-adhoc-new-preliminary-efficacy-data-for-daratumumab-presented-at-ash-dow-jones-news-auf-4investors-de</link>
		<comments>http://www.android-android.de/dgap-adhoc-new-preliminary-efficacy-data-for-daratumumab-presented-at-ash-dow-jones-news-auf-4investors-de/2012-12-09/#comments</comments>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dc:creator>Nachrichten</dc:creator>
				<category><![CDATA[Android Apps]]></category>
		<category><![CDATA[announcement]]></category>
		<category><![CDATA[clinical]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[Daratumumab]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[Efficacy]]></category>
		<category><![CDATA[Genmab]]></category>
		<category><![CDATA[Genmabs]]></category>
		<category><![CDATA[multiple]]></category>
		<category><![CDATA[myeloma]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Preliminary]]></category>
		<category><![CDATA[Presented]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[results]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[statements]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[09.12.2012 &#8211; DJ DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH Genmab A/S 09.12.2012 18:01 Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. =&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; Company Announcement &#8212; Preliminary Quelle: 4investors&#8230; [weiterlesen]]]></description>
				<content:encoded><![CDATA[<p>09.12.2012 &#8211; </p>
<p>DJ DGAP-Adhoc: New Preliminary Efficacy Data for Daratumumab Presented at ASH</p>
<p>Genmab A/S </p>
<p>09.12.2012 18:01 </p>
<p>Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of<br />
EquityStory AG.<br />
The issuer is solely responsible for the content of this announcement. </p>
<p>=&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; </p>
<p>Company Announcement </p>
<p>  &#8212; Preliminary Quelle: 4investors&#8230; <a href="http://www.4investors.de/php_fe/indexdow.php?sektion=dowjones&#038;ID=293153" nofollow>[weiterlesen]</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.android-android.de/dgap-adhoc-new-preliminary-efficacy-data-for-daratumumab-presented-at-ash-dow-jones-news-auf-4investors-de/2012-12-09/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DGAP-Adhoc: Genmab Announces DuoBody Platform Collaboration with Kyowa Hakko Kirin
 &#124; Dow Jones News auf 4investors.de</title>
		<link>http://www.android-android.de/dgap-adhoc-genmab-announces-duobody-platform-collaboration-with-kyowa-hakko-kirin-dow-jones-news-auf-4investors-de/2012-12-05/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dgap-adhoc-genmab-announces-duobody-platform-collaboration-with-kyowa-hakko-kirin-dow-jones-news-auf-4investors-de</link>
		<comments>http://www.android-android.de/dgap-adhoc-genmab-announces-duobody-platform-collaboration-with-kyowa-hakko-kirin-dow-jones-news-auf-4investors-de/2012-12-05/#comments</comments>
		<pubDate>Wed, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dc:creator>Nachrichten</dc:creator>
				<category><![CDATA[Android Apps]]></category>
		<category><![CDATA[AGREEMENT]]></category>
		<category><![CDATA[announcement]]></category>
		<category><![CDATA[ANNOUNCES]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[bispecific]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[Company]]></category>
		<category><![CDATA[DuoBody]]></category>
		<category><![CDATA[Genmab]]></category>
		<category><![CDATA[Genmabs]]></category>
		<category><![CDATA[Kirin
]]></category>
		<category><![CDATA[platform]]></category>
		<category><![CDATA[PRODUCT]]></category>
		<category><![CDATA[results]]></category>
		<category><![CDATA[statements]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[05.12.2012 &#8211; DJ DGAP-Adhoc: Genmab Announces DuoBody Platform Collaboration with Kyowa Hakko Kirin Genmab A/S 05.12.2012 07:51 Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. =&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; Company Announcement - Quelle: 4investors&#8230; [weiterlesen]]]></description>
				<content:encoded><![CDATA[<p>05.12.2012 &#8211; </p>
<p>DJ DGAP-Adhoc: Genmab Announces DuoBody Platform Collaboration with Kyowa Hakko Kirin</p>
<p>Genmab A/S </p>
<p>05.12.2012 07:51 </p>
<p>Dissemination of a Adhoc News, transmitted by DGAP &#8211; a company of<br />
EquityStory AG.<br />
The issuer is solely responsible for the content of this announcement. </p>
<p>=&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; </p>
<p>Company Announcement </p>
<p>- Quelle: 4investors&#8230; <a href="http://www.4investors.de/php_fe/indexdow.php?sektion=dowjones&#038;ID=292768" nofollow>[weiterlesen]</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.android-android.de/dgap-adhoc-genmab-announces-duobody-platform-collaboration-with-kyowa-hakko-kirin-dow-jones-news-auf-4investors-de/2012-12-05/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
